Vanda Pharmaceuticals Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Vanda Pharmaceuticals Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • Vanda Pharmaceuticals Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $6.38M, a 18.1% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $6.38M -$1.41M -18.1% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $6.74M -$1.36M -16.7% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $7.1M -$1.3M -15.4% Dec 31, 2023 10-Q 2024-08-01
Q3 2023 $7.43M -$834K -10.1% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $7.78M -$821K -9.54% Jun 30, 2023 10-Q 2023-07-28
Q1 2023 $8.1M -$848K -9.48% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $8.4M -$872K -9.41% Dec 31, 2022 10-K 2024-02-08
Q3 2022 $8.26M -$1.32M -13.8% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $8.6M -$1.3M -13.1% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $8.95M -$1.25M -12.3% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $9.27M -$1.19M -11.3% Dec 31, 2021 10-K 2023-02-09
Q3 2021 $9.58M -$726K -7.04% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $9.9M -$703K -6.63% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 $10.2M -$681K -6.26% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $10.5M -$721K -6.45% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $10.3M -$1.13M -9.88% Sep 30, 2020 10-Q 2020-10-29
Q2 2020 $10.6M -$1.12M -9.53% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $10.9M -$1.12M -9.33% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $11.2M +$11.2M Dec 31, 2019 10-K 2021-02-11
Q3 2019 $11.4M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $11.7M Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $12M Mar 31, 2019 10-Q 2019-05-03
Q4 2018 $0 Dec 31, 2018 10-K 2020-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.